TARSONS NSE filing

Tarsons Products Q4 FY26 Revenue at ₹121 Crore, Up 7.4%; FY26 Revenue at ₹426 Crore

The RealCase readMedium impact Positive

Tarsons Products reported highest ever quarterly revenue of ₹121 crore in Q4 FY26, up 7.4% YoY. FY26 revenue reached ₹426 crore, up 7.7% YoY. Standalone Q4 revenue grew 4.4% to ₹97 crore, driven by domestic business (+11.7%), while exports declined 13.4%. Consolidated adjusted cash PAT grew 21.4% to ₹112 crore in FY26.

Why it matters

The announcement details strong revenue growth and capacity expansion, which are positive indicators. However, the impact is moderated by the decline in export revenue due to geopolitical issues and the pressure from rising raw material costs, which are being addressed through gradual price increases.

The market read

The company reported record quarterly revenue and strong year-on-year growth for both the quarter and the full year. Despite challenges in the export market, the domestic business showed resilience, and the company is optimistic about future growth due to capacity expansion and market positioning.

Tarsons Products Limited has announced its financial results for the fourth quarter and full year ended March 31, 2026. The company achieved its highest ever quarterly revenue in Q4 FY26, reaching ₹121 crore, a year-on-year growth of 7.4%. For the full financial year FY26, revenue stood at ₹426 crore, marking a growth of 7.7% year-on-year.

On a standalone basis, revenue for Q4 FY26 was ₹97 crore, up 4.4% from ₹93 crore in Q4 FY25. The domestic business showed strong performance with an 11.7% year-on-year growth. However, overall standalone revenue growth was moderated by a 13.4% decline in exports during the quarter, attributed to geopolitical tensions and supply chain disruptions in the Middle East, leading to shipment delays and increased freight costs.

For the full year FY26, standalone revenues grew by 6% year-on-year, with domestic business growing by 7% and exports by 3%. The company's gross margin for standalone business in Q4 FY26 was impacted by high raw material costs, while for FY26 it remained stable at around 71%. EBITDA for Q4 FY26 was ₹32.6 crore and for FY26 was ₹110.1 crore. PAT for FY26 was impacted by higher depreciation and interest expenses due to new capital expenditure.

On a consolidated basis, revenue for Q4 FY26 was ₹120.9 crore, a 7.3% year-on-year growth, and for FY26 it was ₹422.5 crore, a 7.7% growth. Consolidated adjusted cash PAT for FY26 was ₹112 crore, showing a strong growth of 21.4% year-on-year. The company has completed a large-scale investment program to enhance manufacturing capabilities and broaden its product portfolio, with the full commissioning of the capex program expected in the first half of the current financial year.

The management expressed confidence in outperforming industry growth, driven by increased capacities, an expanded product portfolio, strong brand recognition, and strategic overseas expansion. They are monitoring evolving market conditions and expect to capitalize on improving momentum. The company is also gradually increasing prices to offset rising raw material costs.

Filing to action

What to do with a filing like this

Tarsons Products Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Tarsons Products Limited. Read the original for the full detail.

View original filing